HealthInvest Partners’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,432	Closed	-$617K	–	39
2024 Q1	$617K	Buy	24,432 +9,000	+58%	+$227K	0.38%	40
2023 Q4	$360K	Buy	+15,432	New	+$360K	0.28%	44
2022 Q4	$9.1K	Buy	+166	New	+$9.1K	0.02%	39